Strainprint Technologies Partners with Cannabis at Work to Connect Job Hunters with Employers Exclusively Within the Cannabis Industry
Strainprint Technologies Partners with Cannabis at Work to Connect Job Hunters with Employers Exclusively Within the Cannabis Industry Partnership to help place qualified candidates down the right career path FOR IMMEDIATE RELEASE TORONTO (Feb. 26, 2019) – Strainprint Community, an interactive, online platform that provides education and support for the cannabis community is pleased […]
Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
Strainprint™ Technologies Ltd. Welcomes 48North Cannabis Co. parent company of ACMPR Licensed Producer Delshen Therapeutics
Strainprint™ – the leader in cannabis data collection and strain efficacy reporting – is excited to announce that 48North Cannabis (48North) has subscribed to Strainprint’s world-leading cannabis data & analytics platform to help guide its operational growth and product development.
Strainprint Launches Custom App Version For Canna Farms
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Strainprint Opens its Ambassador Program With IMPACT Network
Strainprint™, the leader in cannabis data collection and strain efficacy reporting, is pleased to announce the launch of its Ambassador Research Program. The Strainprint Ambassador program is available to qualified researchers that use Strainprint’s revolutionary data gathering and analytics tools to conduct observational cannabis studies in relation to specific medical conditions.